Alivus Life Sciences Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	4,856	4,709	4,670	4,187	3,516
Depreciation & Amortization	583.42	497.78	406.48	369.2	322.9
Other Amortization	22.67	36.74	14.46	9.57	11.04
Loss (Gain) From Sale of Assets	23.02	10.11	5.58	7.43	5.84
Loss (Gain) From Sale of Investments	-76.15	31.66	-	-	-
Stock-Based Compensation	-	43.75	31.85	34.98	-
Provision & Write-off of Bad Debts	-	-	3.71	48.19	-
Other Operating Activities	309.79	147.03	64.97	320.84	1,101
Change in Accounts Receivable	-2,048	378.6	-1,336	-592.15	81.01
Change in Inventory	-388.55	-826.26	-972.27	-28.23	-1,006
Change in Accounts Payable	187.46	-341.21	907.79	737.49	340.89
Change in Other Net Operating Assets	445.2	-551.93	-735.63	881.29	-491.21
Operating Cash Flow	3,915	4,135	3,060	5,976	3,881
Operating Cash Flow Growth	-5.32%	35.13%	-48.79%	53.97%	99.02%
Capital Expenditures	-1,662	-1,290	-1,628	-1,322	-679.93
Sale of Property, Plant & Equipment	6.29	4.65	1.74	4.69	16.34
Investment in Securities	-4,701	-	1.11	28.05	-28.05
Other Investing Activities	200.13	120.21	157.66	66.7	4.3
Investing Cash Flow	-6,156	-1,165	-1,467	-1,222	-687.34
Short-Term Debt Repaid	-	-	-	-9,329	-2,138
Long-Term Debt Repaid	-44.86	-22.09	-11.28	-13.65	-
Total Debt Repaid	-44.86	-22.09	-11.28	-9,342	-2,138
Net Debt Issued (Repaid)	-44.86	-22.09	-11.28	-9,342	-2,138
Issuance of Common Stock	6.69	-	-	10,119	-
Common Dividends Paid	-	-2,757	-3,859	-1,287	-
Other Financing Activities	-24.14	-15.46	-5.47	-277.64	-
Financing Cash Flow	-62.31	-2,794	-3,876	-787.96	-2,138
Net Cash Flow	-2,304	175.91	-2,283	3,966	1,056
Free Cash Flow	2,253	2,845	1,432	4,654	3,201
Free Cash Flow Growth	-20.81%	98.69%	-69.23%	45.39%	122.55%
Free Cash Flow Margin	9.44%	12.46%	6.63%	21.92%	16.98%
Free Cash Flow Per Share	18.34	23.19	11.69	39.60	29.69
Cash Interest Paid	24.14	15.46	5.47	277.64	-
Cash Income Tax Paid	1,630	1,630	1,536	1,382	1,086
Levered Free Cash Flow	1,390	2,108	553.75	3,756	1,715
Unlevered Free Cash Flow	1,405	2,117	557.17	3,931	2,262
Change in Working Capital	-1,804	-1,341	-2,137	998.4	-1,076

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.